Navigation Links
Dr. Farshchian to Interview Dr. Daniel Ramos on " The Arthritis Show"
Date:1/13/2013

MIAMI (PRWEB) January 13, 2013

On January the 13th at 5:30, Dr. Daniel Ramos will be appearing on "The Arthritis Show" as a guest.

Dr. Daniel Ramos: Dr. Ramos is a Physical Therapist. He provides individualized assessment and treatment based on each patient's condition or medical concern. His practice is located in the city of Aventura, Florida.

A.J. Farshchian MD will continue to push the envelope, like he did in the past seasons. U.S.A. based physician, Dr. Farshchian, is a medical author, humanitarian, and active Republican member. He is best known for coining the term "orthopedic regenerative medicine." Dr. Farshchian is recognized as a leading authority in the new clinical science of regenerative medicine. Viewers can enjoy watching the show live on http://www.arthritisusa.net as it streams live on the internet Mondays, Wednesdays and Fridays at 5:30 P.M. The show also broadcasts on BuenoVision daily at 11:30 A.M.

My Medicine TV programs are independently produced by Mymedicinetv.com. The show provides its viewers an in depth opportunity to find solutions to the health problems from some of the top leaders in health care from across the world. Each exclusive segment is taped in their state of the art south Florida studio."The Arthritis Show" is a global information source dedicated to patients with arthritis and sports injuries.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10304515.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Dr. Farshchian: Muscle Atrophy a Major Problem with Arthritis, is Being Treated with Cell Therapy at the Center for Regenerative Medicine
2. Dr. Farshchian: Trochanter Bursitis is Now Treated at the Center for Regenerative Medicine
3. Dr. Farshchian: Tibialis Posterior Dysfunction is Now Being Treated at the Center for Regenerative Medicine in Miami
4. Muscular Contusions Are Now Being Treated Successfully by Dr. Farshchian Using Cell Therapy
5. Dr. Farshchian: Muscle Atrophy a Major Problem with Arthritis, is Now Being Treated with Regenerative Medicine
6. Dr. Farshchian: Labrum Tear is Now Being Treated With Cell Therapy at the Center for Regenerative Medicine Using
7. Dr. Farshchian: Muscular Contusions are Now Being Treated Successfully at The Center for Regenerative Medicine in Miami
8. Dr. Farshchian: New treatment on Muscle Atrophy, now available at the Center for Regenerative Medicine
9. Dr. Farshchian: Trochanter Bursitis is Now Treated at the Center for Regenerative Medicine
10. Dr. Farshchian: Rotator Cuff Injuries are being Treated Now Using Cell Therapy at the Center for Regenerative Medicine
11. Dr. Farshchian: Tibialis Posterior Dysfunction is Now Being Treated at The Center for Regenerative Medicine in Miami
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013 ... be holding a lupus support ... June 10th. , Meeting Details: ... p.m. – 8 p.m., Location: ... Sparrow Hospital),                  1200 East ...
(Date:5/20/2013)... Lake City, UT (PRWEB) May 20, 2013 ... named one of Select Health’s Select 25 winners ... receive $2500 from Select Health. Know Greater Heroes is a ... local elementary schools to teach children how to eat right, ... student athletes participate in the Know Greater Heroes program each ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Osborn’s ... successor to Anne G. Osborn’s 1993 award winning book ... of the all-time bestselling neuroradiology texts. , In ... special touch to make complex topics visually appealing and ... of brain imaging together with spectacular pathology examples, relevant ...
(Date:5/20/2013)... May 20, 2013 Nearly 20 percent of ... U.S. are refused for transplant due to factors ranging ... filtering units to the organ going too long without ... discarded, these organs could be "recycled" to help solve ... Wake Forest Baptist Medical Center and colleagues, reporting in ...
(Date:5/20/2013)... 2013 What:    USO Care ... President, USO and CEO , ... Initiatives and Partners, Sesame Street , ... from:,              • ... • U.S. House of Representatives ...
Breaking Medicine News(10 mins):Health News:SLCC Know Greater Heroes Program Named to Select 25 2Health News:SLCC Know Greater Heroes Program Named to Select 25 3Health News:Osborn’s Brain from Amirsys Publishing Receives Doody’s Top Honors 2Health News:Study suggests new source of kidneys for transplant 2Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 2Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 3Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 4
... By Amanda Gardner HealthDay Reporter , TUESDAY, ... belly fat of 10 heart attack patients managed to improve ... is the first time this type of therapy has been ... Tuesday at the American Heart Association,s annual meeting in Chicago. ...
... Steven Reinberg HealthDay Reporter , TUESDAY, Nov. ... advisers were weighing Tuesday whether to recommend the first ... the autoimmune disease lupus. The drug, belimumab (Benlysta), ... treat patients who suffer from systemic lupus erythematosus. ...
... study from the Swedish medical university Karolinska Institutet shows ... aneurysm. These drugs, which block cysteinyl-leukotrienes, could reduce the ... of the aortic wall, and thus the risk of ... the need for complicated and risky surgery. The results ...
... MONDAY, Nov. 15 (HealthDay News) -- It rarely happens, ... and sponges are left inside children undergoing surgery, according to ... mishaps were not more likely to die, but the errors ... long and cost more than double that of the average ...
... The risk of radiation-induced breast cancer from mammography screening ... saved, according to a new study appearing online and in ... "Recently, there have been reports in the press focusing on ... periodic screening," said the study,s lead author, Martin J. Yaffe, ...
... factor 7 (rFVIIa) a drug used to treat ... not recommended because of the potential for adverse events, ... Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100408.pdf. Recombinant activated factor ... of bleeding in hemophilia patients. It is also used ...
Cached Medicine News:Health News:Study Hints at Stem Cells From Belly Fat as Treatment for Heart Attack 2Health News:Study Hints at Stem Cells From Belly Fat as Treatment for Heart Attack 3Health News:FDA Advisers Consider New Lupus Drug 2Health News:Aortic aneurysm treatable with asthma drugs 2Health News:Sponges, Surgical Tools Sometimes Left in Kids After Operation 2Health News:Sponges, Surgical Tools Sometimes Left in Kids After Operation 3Health News:Radiation fears should not deter women from mammography screening 2Health News:Hemostatic drug less effective than originally predicted 2
(Date:5/20/2013)... May 20, 2013  Echo Pharma Acquisition Limited ("Royalty ... Irish Takeover Rules (the "Announcement"), a firm intention to ... ELN ) to $12.50 per share in cash.  ... not conditional on due diligence.  The $1.00 per share ... reserved the right to waive down the Acceptance Threshold ...
(Date:5/20/2013)...  Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical company ... technology to deter prescription drug abuse today announced ... Soscia , has been chosen as a ... Health-Care Heroes Awards. The awards are presented annually ... individuals and organizations demonstrating excellence and deserving recognition ...
(Date:5/20/2013)... -- Rhythm announced today the presentation of results from a ... symptoms among diabetic patients in the U.S. than previously ... with both type 1 and type 2 diabetes, but ... more common type 2 disease. ... of Medicine at Harvard Medical School and Director of ...
Breaking Medicine Technology:Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 4Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 5Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 6Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 7Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 8Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 9Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 10Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 11Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 2Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 3Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 4
... This May, Joao Pedras-Vasconcelos, Visiting Associate, Therapeutic ... European industry experts at Pharma IQ,s to discuss FDA ... Over the last two years, the regulations have been ... there has been some confusion within the industry as ...
... 2011 Morphotek®, Inc., a subsidiary of Eisai ... assets relating to a proprietary tumor targeting platform ... payment and future development milestones. TMI, a biotechnology ... the tumor-targeting peptide (TTP) platform capable of delivering ...
Cached Medicine Technology:FDA to Address Industry Questions About Biosimilar Regulations at the Pharma's IQ Immunogenicity Event 2Morphotek®, Inc. Announces Acquisition of Tumor Targeting Assets From Transmolecular, Inc. 2Morphotek®, Inc. Announces Acquisition of Tumor Targeting Assets From Transmolecular, Inc. 3
Safilo Design, a state-of-the art ophthalmic collection that blends technology with minimalist sophistication. Each style comes with a sleek silver-colored hard case with magnetic closure....
Inquire...
The latest VALENTINO eyewear collection is a refined expression of sophisticated luxury,balancing ultimate feminine, chic styles against understated, minimalist mens models....
The Claiborne brand provides the perfect look for the man who wants to be comfortable and relaxed, yet look appropriate for each occasion....
Medicine Products: